Correlation between the serum level of ferritin and D-dimer and the severity of COVID-19 infection

Author:

AbdelFattah Eman BadawyORCID,Madkour Ashraf Mokhtar,Amer Shimaa Mohamed I.,Ahmed Noha Othman

Abstract

Abstract Background Many laboratory biomarkers were used for diagnosis of COVID-19 infection; however, their accuracy to assess the severity and prognosis are still to be evaluated. This study aims to correlate between the serum ferritin and D-dimer levels and the severity of COVID-19 infection and its outcome. Results Retrospective data retrieval of 150 confirmed COVID-19 infection patients admitted in Ain Shams University Specialized Hospital El Obour during period between April and July 2020 were studied. Ninety-six were survivors and 54 were non-survivors. The number of co-morbidities, the level of D-dimer and serum ferritin were correlated with ICU admission, need for mechanical ventilation and mortality with P value < 0.0001. Serum ferritin and D-dimer levels were significantly correlated with degree of HRCT chest severity with P value < 0.0001. The cut-off value of D-dimer for mortality was 700 ng/ml (sensitivity 83.33%, specificity 59.38%), and that for serum ferritin was 300 ng/ml (sensitivity 88.89%, specificity 58.33%), cut-off value of D-dimer for ICU admission was 863 ng/ml and that for serum ferritin was 300 ng/ml, cut-off value of D-dimer for mechanical ventilation was 700 ng/ml, and that for serum ferritin was 600 ng/ml. Conclusion D-dimer and serum ferritin are important biomarkers in predicting the mortality, ICU admission and need for mechanical ventilation in COVID-19 subjects. Thus helps in early detection of risk of progression and improving outcome. The current study also provides probable cut-off values for both biomarkers above which mortality, ICU admission, and mechanical ventilation need can be expected. Trial registration ClinicalTrials.gov ID: NCT0567281. Retrospectively registered. 4th January 2023. https://register.clinicaltrials.gov/prs/app/action/SelectProtocol?sid=S000CT6C&selectaction=Edit&uid=U00056R5&ts=2&cx=-tlu9xu.

Publisher

Springer Science and Business Media LLC

Subject

General Earth and Planetary Sciences,General Environmental Science,General Medicine

Reference44 articles.

1. CDC. 2019 Novel Coronavirus, Wuhan, China. CDC. Available at https://www.cdc.gov/coronavirus/2019-ncov/about/index.html. January 26, 2020; Accessed: 1 Dec 2021

2. Cucinotta D, Vanelli M (2020) WHO declares COVID-19 a pandemic. Acta Biomed 91(1):157–160

3. WHO. Clinical management of COVID-19: interim guidance. https://apps.who.int/iris/bitstream/handle/10665/332196/WHO-2019-nCoV-clinical-2020.5-eng.pdf. September 14,2022 accessed December 2022

4. Sharma S, Aggarwal A, Sharma R, Patras E, Singhal A (2022) Correlation of chest CT severity score with clinical parameters in COVID-19 pulmonary disease in a tertiary care hospital in Delhi during the pandemic period. Egypt J Radiol Nucl Med 53:166

5. Saeed G, Gaba W, Shah A, Al Helali A, Raidullah E, Al Ali A, Elghazali M, Ahmed D, Al Kaabi S, Almazrouei S (2021) Correlation between chest CT severity scores and the clinical parameters of adult subjects with COVID-19 pneumonia. Radiol Res Pract. 2021:6697677

Cited by 3 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3